BIOCHEMICAL BASIS FOR DEFECTIVE DIFFERENTIATION IN GRANULOCYTIC LEUKEMIA
BIOCHEMICAL BASIS FOR DEFECTIVE DIFFERENTIATION IN GRANULOCYTIC LEUKEMIA
批准号:
3817352
负责人:
W H EVANS
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The main thrust of this work is to develop biochemical methods for
the early diagnosis of granulocytic leukemia and methods for
inducing leukemic cells to develop some or all of their functional
properties as a means of partially or completely restoring host
defense mechanisms in leukemia patients. Work is first aimed at
establishing which of the many biochemical steps involved in normal
granulocyte differentiation are controlled by humoral regulators.
The results will be compared with those obtained from similar
studies on leukemic cells at corresponding stages of maturity in
order to determine, the nature and potential reversibility of the
arrested differentiation steps. Biochemical analyses are carried
out on mature and immature granulocytes isolated from blood and
bone marrow and the effects of cell regulators on granulocyte
differentiation, as measured by changes in the synthesis of
specific cellular components, are studied in a defined culture
system previously developed in this laboratory. Possible
relationships between transforming genes in leukemic myeloblasts
and factors involved in the regulation of normal granulocyte
differentiation are under investigation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
THE BIOCHEMICAL BASIS FOR DEFECTIVE DIFFERENTIATION IN GRANULOCYTIC LEUKEMIA
-
批准号:4691689
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:W H EVANS
-
依托单位:
BIOCHEMICAL BASIS FOR DEFECTIVE DIFFERENTIATION IN GRANULOCYTIC LEUKEMIA
-
批准号:3939187
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:W H EVANS
-
依托单位:
BIOCHEMICAL BASIS FOR DEFECTIVE DIFFERENTIATION IN GRANULOCYTIC LEUKEMIA
-
批准号:3821216
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:W H EVANS
-
依托单位:
THE BIOCHEMICAL BASIS FOR DEFECTIVE DIFFERENTIATION IN GRANULOCYTIC LEUKEMIA
-
批准号:3962889
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:W H EVANS
-
依托单位:
海外基金